Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Eli lilly and company crawled time : 03:00 save search
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published: 2024-03-13 (Crawled : 03:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.59%
H: 0.01%
C: -1.45%
drug disease report research global market
Global Therapeutic Antibody Market Research Report 2024: Monoclonal, Bispecific, Drug Conjugates, Others Insights and Forecasts 2019-2029
Published: 2024-02-28 (Crawled : 03:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.36%
H: 0.1%
C: -0.6%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.6%
H: 0.02%
C: -1.03%
drug report antibody research global market
Biosimilar Hormones Global Market Report 2024 - Niche Sectors Record Notable Market Contributions
Published: 2024-02-14 (Crawled : 03:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.71%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.38%
H: 2.44%
C: 1.54%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.16%
H: 0.43%
C: -2.76%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.21%
H: 0.34%
C: 0.07%
biosimilar report global market
South Africa Biopharmaceuticals Market Outlook Report 2023-2028: Innovating for Wellness - Industry Focuses on Precision Medicine
Published: 2023-08-16 (Crawled : 03:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.7%
H: 1.0%
C: -0.21%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.33%
H: 0.0%
C: 0.0%
report wellness market africa
RemeGen and Innovent Collaborate on Clinical Trials to Evaluate the Potential of RC88 and RC108 Combined with PD-1 Therapy for Advanced Solid Tumors
Published: 2023-07-10 (Crawled : 03:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.19%
H: 0.38%
C: 0.04%
rc88 tumors trials potential therapy
Global Menopause Drug Market Trends and Growth Opportunity Report 2022-2023 & 2030
Published: 2023-05-17 (Crawled : 03:00) - prnewswire.com
SGIOY | $11.44 1.96% 72K
|
Manufacturing
|
| O: 0.88%
H: 2.07%
C: -1.04%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.49%
H: 0.02%
C: -0.82%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.25%
H: 0.03%
C: -1.15%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.49%
H: 0.03%
C: -0.3%
drug report global trends growth market
The Diabetes Market in the Netherlands is Expected to Reach $3.36 Billion in 2028
Published: 2023-02-22 (Crawled : 03:00) - prnewswire.com
TRUMF | $16.928 -17.59% 1.9K
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: -1.62%
TRUMY | $16.507 0.79% 34K
|
Manufacturing
|
| O: -1.93%
H: 1.83%
C: 0.15%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.37%
H: 1.18%
C: 0.11%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.4%
H: 0.59%
C: -0.53%
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: 0.58%
H: 0.36%
C: -2.08%
netherlands expected diabetes market
Burning Rock Reports Third Quarter 2022 Financial Results
Published: 2022-11-16 (Crawled : 03:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.01%
H: 1.97%
C: 0.84%
BNR | $0.72 -10.0% -11.11% 24K
|
Health Services
|
| O: 6.58%
H: 0.41%
C: -6.58%
financial results
FDA Approves Lilly and Incyte's OLUMIANT® (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata
Published: 2022-06-14 (Crawled : 03:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -2.09%
H: 0.41%
C: -1.96%
olumiant fda
FDA Advisory Committee Votes to Recommend Additional Data for Sintilimab Submission
Published: 2022-02-11 (Crawled : 03:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
fda submission
Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules
Published: 2022-01-18 (Crawled : 03:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -3.01%
H: 2.38%
C: 1.78%
therapeutics collaboration
Innovent Announces Inclusion of the Company's Stock (01801.HK) in the Hang Seng China Enterprises Index
Published: 2021-11-22 (Crawled : 03:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.61%
H: 0.67%
C: -0.68%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -1.1%
H: 0.22%
C: -1.92%
china
Innovent Releases the ORIENT-31 Phase 3 Study First Interim Analysis Results of Sintilimab plus BYVASDA (bevacizumab biosimilar injection) and Chemotherapy in Patients with EGFR-mutated Nonsquamous Non-small Cell Lung Cancer who Progressed After EGFR-TKI Therapy at ESMO Virtual Plenary 2021
Published: 2021-11-22 (Crawled : 03:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.61%
H: 0.67%
C: -0.68%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -1.1%
H: 0.22%
C: -1.92%
lung cancer therapy injection results cancer phase 3 biosimilar
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.